Abiraterone

Name: Abiraterone | 154229-19-3
Brand: US-CATO
SKU: S57C4X-1070_10_MG
Price: 19998.0 USD
Availability: InStock

Cat. No S57C4X-1070_10_MG

Vendor: US-CATO

Product Information

Product Name

Abiraterone

Brand Name

US-CATO

Product Number

C4X-1070

CAS

154229-19-3

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

132971

IUPAC Name

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopentaaphenanthren-3-ol

InChI Key

GZOSMCIZMLWJML-VJLLXTKPSA-N

SMILES

CC@12CCC@@H(CC1=CCC@@H3C@@H2CCC@4(C@H3CC=C4C5=CN=CC=C5)C)O

References Data Source From Pubchem

Years of life lost and mortality rates from metastatic prostate cancer in contemporary African Americans vs. Caucasians

Publication Name: World Journal of Urology

Publication Date: 2026-06-06

DOI: 10.1007/s00345-026-06295-3|10.1007/s00345-026-06463-5

[Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer]

Publication Name: Urologie (Heidelberg, Germany)

Publication Date: 2026-05

DOI: 10.1007/s00120-025-02747-7

Challenges and advances in drug resistance and tolerance in cancer

Publication Name: Journal of experimental & clinical cancer research : CR

Publication Date: 2026-03-04

DOI: 10.1186/s13046-026-03665-y

Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534

Publication Name: Investigational New Drugs

Publication Date: 2026-03-03

DOI: 10.1007/s10637-026-01600-8

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity

Publication Name: British Journal of Cancer

Publication Date: 2026-03-03

DOI: 10.1038/s41416-026-03359-4

Abiraterone

Product Information

General Information

References Data Source From Pubchem

Years of life lost and mortality rates from metastatic prostate cancer in contemporary African Americans vs. Caucasians

[Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer]

Challenges and advances in drug resistance and tolerance in cancer

Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity

Abiraterone

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Abiraterone

Product Information

General Information

References Data Source From Pubchem

Years of life lost and mortality rates from metastatic prostate cancer in contemporary African Americans vs. Caucasians

[Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer]

Challenges and advances in drug resistance and tolerance in cancer

Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity

Abiraterone

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register